US approves Medtronic's high-output ICD (implantable cardioverter defibrillator):
This article was originally published in Clinica
The US FDA has approved Medtronic's high-energy Maximo implantable cardioverter defibrillator (ICD). The ICD delivers 35 joules of energy for patients requiring a bigger shock to regulate their heartbeat. The device, which is available in single or dual chamber models, combines a small size, fast charge times and increased pain-free therapy. With a working life of 8-10 years Maximo is one of the longest-lasting devices on the market, making it very cost-effective, according to the company The RapidRead telemetry feature has also been improved to complete operations in seconds rather than minutes.